Sera Prognostics (SERA) EBITDA Margin (2020 - 2026)
Sera Prognostics posted quarterly EBITDA Margin of 61750.0% for Q1 2026, down 4024737.0% year-on-year from N/an in Q1 2025, and up 21.71% on a QoQ basis from 78870.0% in Q4 2025.
Sera Prognostics (SERA) has 7 years of EBITDA Margin data on file, last reported at 61750.0% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin fell 4024737.0% year-over-year to 61750.0%; the trailing twelve-month figure through Mar 2026 stood at 56491.23% (down 2802949.0% YoY), and the FY2025 full-year result was 39167.9%, up 345937.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 61750.0%, up from 78870.0% in the prior quarter.
- Across five years, EBITDA Margin topped out at 8745.53% in Q2 2023 and bottomed at 78870.0% in Q4 2025.
- The 5-year median for EBITDA Margin is 23537.52% (2024), against an average of 30223.3%.
- The widest annual swing landed in 2022, when EBITDA Margin soared 3391846 bps; it then sank 4215750 bps in 2025.
- A 5-year view of EBITDA Margin shows it stood at 14704.62% in 2022, then decreased by 22 bps to 17868.29% in 2023, then slumped by 105 bps to 36712.5% in 2024, then slumped by 115 bps to 78870.0% in 2025, then gained by 22 bps to 61750.0% in 2026.
- The last three EBITDA Margin figures came in at 61750.0% (Q1 2026), 78870.0% (Q4 2025), and 48068.75% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Sera Prognostics | 30.02 Mn | 30.02 Mn | -28,000.00 | -61,750.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61,750.00% |
| Dec 31, 2025 | -78,870.00% |
| Sep 30, 2025 | -48,068.75% |
| Jun 30, 2025 | -46,923.53% |
| Mar 31, 2025 | -21,502.63% |
| Dec 31, 2024 | -36,712.50% |
| Sep 30, 2024 | -25,572.41% |
| Jun 30, 2024 | -34,720.83% |
| Dec 31, 2023 | -17,868.29% |
| Sep 30, 2023 | -17,028.57% |
| Jun 30, 2023 | -8,745.53% |
| Mar 31, 2023 | -10,041.00% |
| Dec 31, 2022 | -14,704.62% |
| Sep 30, 2022 | -12,716.09% |
| Jun 30, 2022 | -14,976.92% |
| Mar 31, 2022 | -33,371.05% |
| Dec 31, 2021 | -48,623.08% |
| Sep 30, 2021 | -42,973.91% |
| Jun 30, 2021 | -31,535.00% |
| Mar 31, 2021 | -48,915.38% |
| Dec 31, 2020 | -89,583.33% |
| Sep 30, 2020 | -101,440.00% |
| Jun 30, 2020 | -71,350.00% |